Wedbush Maintains Neutral On Qiagen Shares, $20 PT
In a research report issued today, Wedbush analyst Zarak Khurshid maintained a Neutral rating on Qiagen (NASDAQ:QGEN) with a price target of $20.
Khurshid said, “Expecting in-line sales and EPS. We forecast sales of $336 MM and EPS of $0.27 when QGEN reports 3Q14 results after the market close on Wednesday October 29, 2014. This will be followed by a conference call on at 5pm EST (dial-in 855-272-3518), passcode: 359145#, webcast: www.qiagen.com/About- Us/Investors/Events-and-Presentations/Conference-Calls. Consensus estimates are for $337 MM in sales and $0.27 in EPS.”
According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Zarak Khurshid has a total average return of 3.4% and a 67.7% success rate. Khurshid is ranked #1250 out of 3343 analysts.